Antinociceptive effects of cardamonin in mice: Possible involvement of TRPV1, glutamate and opioid receptors by Chung, Pui Ping et al.
Antinociceptive effects of cardamonin in mice: Possible involvement of TRPV1, 
glutamate and opioid receptors 
 
ABSTRACT 
Pain is one of the most common cause for hospital visits. It plays an important role in 
inflammation and serves as a warning sign to avoid further injury. Analgesics are used to 
manage pain and provide comfort to patients. However, prolonged usage of pain treatments 
like opioids and NSAIDs are accompanied with undesirable side effects. Therefore, research 
to identify novel compounds that produce analgesia with lesser side effects are necessary. The 
present study investigated the antinociceptive potentials of a natural compound, cardamonin, 
isolated from Boesenbergia rotunda (L) Mansf. using chemical and thermal models of 
nociception. Our findings showed that intraperitoneal and oral administration of cardamonin 
(0.3, 1, 3, and 10 mg/kg) produced significant and dose-dependent inhibition of pain in 
abdominal writhing responses induced by acetic acid. The present study also demonstrated that 
cardamonin produced significant analgesia in formalin-, capsaicin-, and glutamate-induced 
paw licking tests. In the thermal-induced nociception model, cardamonin exhibited significant 
increase in response latency time of animals subjected to hot-plate thermal stimuli. The rota-
rod assessment confirmed that the antinociceptive activities elicited by cardamonin was not 
related to muscle relaxant or sedative effects of the compound. In conclusion, the present 
findings showed that cardamonin exerted significant peripheral and central antinociception 
through chemical- and thermal-induced nociception in mice through the involvement of 
TRPV1, glutamate, and opioid receptors. 
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